
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vertex Pharmaceuticals (United States), United States, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
49%
Total
Publications
2.3K
Total Open
Publications
1.2K
Total
Citations
173K
Open Access
Percentage
49%
Total
Publications
2.3K
Total Open
Publications
1.2K
Total
Citations
173K
Breakdown
Publisher Open
17%
Both
21%
Other Platform Open
11%
Closed
51%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
293
Hybrid 23%
205
No Guarantees 44%
382
Other Platform Open
Domain 67%
506
Institution 44%
329
Other Internet 18%
138
Preprint 9%
64
Public 4%
30
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 511 |
doaj.org OAI-PMH Repository | Institution | 157 |
DOI | Other Internet | 125 |
bioRxiv | Preprint | 30 |
Figshare | Public | 29 |
Unknown Repository | Other Internet | 27 |
Europe PMC | Domain | 24 |
Office of Scientific and Technical Information | Institution | 19 |
University of Edinburgh | Institution | 18 |
University of Oxford | Institution | 15 |